Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure

ClinicalTrials.gov ID: NCT02653482

Public ClinicalTrials.gov record NCT02653482. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 3, 2026, 1:06 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary purpose of this study is to evaluate the impact of dapagliflozin, as compared with placebo, on heart failure disease-specific biomarkers, symptoms, health status, and quality of life in patients with chronic heart failure with reduced systolic function.

Study identification

NCT ID
NCT02653482
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Saint Luke's Health System
Other
Enrollment
263 participants

Conditions and interventions

Eligibility (public fields only)

Age range
19 Years to 119 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 2, 2016
Primary completion
Jun 27, 2019
Completion
Jun 27, 2019
Last update posted
Apr 20, 2022

2016 – 2019

United States locations

U.S. sites
25
U.S. states
16
U.S. cities
23
Facility City State ZIP Site status
Heart Group of the Eastern Shore Fairhope Alabama 36532
University of Southern Califiornia Los Angeles California 90032
First Coast Cardiovascular Institute Jacksonville Florida 32256
Charlotte Heart Group Research Center Port Charlotte Florida 33952
Emory University Atlanta Georgia 30303
NorthShore University HealthSystem Research Institute Evanston Illinois 60201
Northwestern University Evanston Illinois 60208
Advocate Health and Hospitals Oakbrook Terrace Illinois 60181
University of Maryland Baltimore Maryland 21201
Walter Reed National Military Medical Center Bethesda Maryland 20889
Brigham & Women's Hospital Boston Massachusetts 02115
Henry Ford Health System Detroit Michigan 48202
Mayo Clinic Rochester Minnesota 55905
Freeman Health System Joplin Missouri 64804
Truman Medical Center Kansas City Missouri 64108
Saint Luke's Hospital of Kansas City Kansas City Missouri 64111
Washington University St Louis Missouri 63110
New York University New York New York 10016
St. Francis Hospital Roslyn New York 11576
Duke University Durham North Carolina 27705
Eastern Nephrology Associates New Bern North Carolina 28562
Cleveland Clinic Cleveland Ohio 44195
University of Pennsylvania Philadelphia Pennsylvania 19106
Vanderbilt University Nashville Tennessee 37232
University of Texas Southwestern Dallas Texas 75390

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02653482, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 20, 2022 · Synced Sep 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02653482 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →